#United States #New York #Levi & Korsinsky #Securities Fraud #Inspire Medical

Important Update for Inspire Medical Systems Investors

Levi & Korsinsky, LLP has issued an important notice to shareholders regarding a class action securities lawsuit that is pertinent to Inspire Medical Systems, Inc. (NYSE: INSP). This announcement highlights a significant lead plaintiff deadline set for January 5, 2026, which concerns investors who experienced financial losses due to alleged fraud involving the company from August 6, 2024, to August 4, 2025.

Overview of the Legal Action

The class action aims to recover losses for investors adversely affected by alleged securities fraud. The lawsuit claims that Inspire Medical Systems made misleading statements and omitted critical information about the launch of its new product, Inspire V. Originally touted as a breakthrough, the product's launch faced numerous challenges. Reports indicate that the demand was lackluster as providers struggled with surplus inventory and exhibited hesitancy in transitioning to the new treatment. Moreover, the company allegedly failed to uphold various essential tasks necessary for a successful product introduction, causing significant disappointment among investors.

Details of Allegations

Among the specific allegations outlined in the complaint, it is stated that Inspire Medical had not completed proper training and onboarding for many of its treatment center customers. Furthermore, the company failed to establish crucial IT systems, including the customer approval process necessary for effective operations. Insufficient updates to critical insurer claims software were also highlighted, leading to issues in claims processing and payment. According to legal documents, Inspire had not secured Medicare reimbursement arrangements prior to the launch date, which contributed to the resultant operational failures.

Next Steps for Affected Investors

For those who endured losses due to their investment in Inspire Medical Systems during the specified timeframe, the law firm encourages them to consider acting before the January 5, 2026 deadline to request their appointment as lead plaintiff. Importantly, this step does not necessitate serving as a lead plaintiff to partake in any potential recovery from the lawsuit.

Participation Without Financial Burden

Levi & Korsinsky emphasizes that there are no costs associated with participating in this case for class members, who may be entitled to compensation without facing any out-of-pocket fees. The firm reassures that anyone interested to participate can do so without any obligation.

Why Choose Levi & Korsinsky?

With over two decades of experience in securities litigation, Levi & Korsinsky has secured substantial recoveries for aggrieved shareholders and is known for its successful track record in high-stakes cases. The firm has a dedicated team comprising more than 70 professionals focused on providing the best representation for its clients in complex securities matters. Recognized for seven consecutive years in ISS Securities Class Action Services' Top 50 Report, the firm maintains its stature as one of the leading securities litigation firms across the United States.

Contact Information

Investors who wish to learn more about their options in relation to this class action lawsuit are invited to reach out to Joseph E. Levi, Esq., at the provided email or phone number:

• - Email: [email protected]
• - Phone: (212) 363-7500

Levi & Korsinsky, LLP
33 Whitehall Street, 27th Floor
New York, NY 10004

For further details and to express interest in the class action, investors can follow the link here.

This case represents an important opportunity for affected shareholders of Inspire Medical Systems, Inc. to regain their losses and ensure accountability in corporate practices.